Brain Barrier Research: Mechanisms, Function, Regulation, and Therapeutic Medicine

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".

Deadline for manuscript submissions: closed (9 January 2026) | Viewed by 1134

Special Issue Editor


E-Mail Website
Guest Editor
CICS-UBI—Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, 6200-506 Covilhã, Portugal
Interests: choroid plexus; cerebrospinal fluid; brain homeostasis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Brain function is ensured by the presence of important interfaces, including the brain barriers that separate the central nervous system from the blood. There are three main barriers: the blood–brain barrier (BBB), the blood–cerebrospinal fluid barrier (BCSFB), and the arachnoid barrier (AB). The BBB presents an extensive surface area and is mainly formed by brain capillary endothelial cells but also by astrocytes, pericytes, and neurons. The BCSFB is composed of choroid plexus epithelial cells that, besides barrier function, are also responsible for most of the CSF production and secretion into brain ventricles, the biosynthesis of proteins and hormones, and chemical surveillance. The AB, composed of epithelial cells of the meninges, is another interface between the blood and the CSF and participates in CSF formation. At all three barriers, the paracellular pathway is highly restricted by the tight junctions that connect the brain endothelial cells, choroid plexus epithelial cells, or epithelial cells of the meninges. In addition, they present specific transporters and metabolic enzymes that ensure the composition of brain fluids and central nervous system (CNS) homeostasis. Therefore, the dysfunction of these structures has been related to CNS disorders. On the other hand, brain barriers, particularly the BBB and BCSFB, have been a major obstacle to brain drug delivery. For this reason, the development of drugs that can cross these structures and reach their targets in the brain remains a challenge.

This Special Issue aims to highlight the pathophysiological mechanisms of brain barriers, contributing to a better understanding of brain barrier functions and how their impairment can be related to CNS disorders, including neurodegenerative disorders, tumors, and cancer. Additionally, it is of the utmost importance to investigate new drug targets at brain barriers. Thus, we invite experts working in the field of brain barriers to contribute their recent research to this Special Issue.

Prof. Dr. Ana Catarina Duarte
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • brain barriers
  • brain homeostasis
  • neurodegeneration
  • neuroinflammation
  • brain drug delivery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 1999 KB  
Article
Potential Protective Effects of Naloxone in Traumatic Brain Injury Through JAK2/STAT3 Signaling Modulation
by Dong Hyuk Youn, Harry Jung, Ji Hyeon Lee, Seongwon Pak, Sung Woo Han, Jong-Tae Kim, Kang Song, Hae Ryong Choi, Gui Seung Han, Young-Suk Kwon, Jeong Jin Park, Jin Pyeong Jeon, Jae Jun Lee and Jong-Kook Rhim
Life 2026, 16(3), 480; https://doi.org/10.3390/life16030480 - 16 Mar 2026
Viewed by 660
Abstract
Background: We evaluated the potential neuroprotective effects of naloxone in moderate traumatic brain injury (TBI), focusing on its ability to alleviate neuroinflammation, reduce cognitive impairment, and to influence Janus tyrosine kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling markers. [...] Read more.
Background: We evaluated the potential neuroprotective effects of naloxone in moderate traumatic brain injury (TBI), focusing on its ability to alleviate neuroinflammation, reduce cognitive impairment, and to influence Janus tyrosine kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling markers. Methods: Male C57BL/6J mice were used to establish an in vivo model of moderate TBI using a stereotaxic impactor. Immediately post-injury, naloxone was administered intraperitoneally (1 mg/kg/day) for 7 days. A total of 72 mice were divided into four groups: Normal, normal with naloxone, TBI, and TBI with naloxone (18 mice in each group). Immunohistochemical analyses and cognitive functions were evaluated across the groups. Results: TBI mice treated with naloxone exhibited significantly reduced brain swelling and cortical tissue loss compared to untreated mice. Naloxone reduced Transforming growth factor beta 2 (TGF-β2) and increased interleukin 11 (IL-11) expression in the brain. Additionally, levels of JAK2, STAT3, and B-cell lymphoma 2 (Bcl-2) were significantly elevated following treatment, while expressions of Tumor protein p53 (p53), Caspase 3, Microtubule-associated proteins 1A/1B light chain 3B (LC3B), and Sequestosome 1 (p62) were reduced. Fluorescence intensities of ionized calcium binding adaptor molecule (Iba-1) and dichloro-dihydro-fluorescein diacetate (DCFH-DA) were enhanced, indicating decreased microglial activation and reactive oxygen species (ROS) production due to naloxone treatment. Cognitive function tests revealed improved performance in TBI mice treated with naloxone, demonstrated by decreased alteration rates in the Y-maze test and improved preference index scores in the novel object recognition (NOR) test. Conclusions: Naloxone shows potential for neuroprotection and enhanced cognitive performances, which may be associated with modulation of JAK2/STAT3 signaling in a mouse model of moderate TBI. Full article
Show Figures

Figure 1

Back to TopTop